• +1 (732) 369 9777
  • +1 (609) 857 6083
  • enquiry@dimensionmarketresearch.com

logo Animal Health Market

Comprehensive Industry Landscape and Strategic Outlook

  • About Us
  • Insight
    Trending Reports Latest Reports
  • Industries
    Aerospace & Defence
    Agriculture & Horticulture
    Automotive
    BFSI & Education
    Chemical & Material
    Consumer Goods
    Electrical & Semiconductor
    ICT & TMT
    Energy & Power
    Food & Beverages
    Industry Automation & Equipment
    Manufacturing & Construction
    Medical Devices & Healthcare IT
    Metals & Minerals
    Packaging & Logistics
    Pharmaceuticals & Healthcare
    Sports & Fitness
  • News And Media
  • Contact us
Speak to Analyst
Request Free Sample
/images/logo.png
  • home
  • Pharmaceuticals & Healthcare
  • Animal Health Market

Animal Health Market By Animal Type (Production Animal, Companion Animal), By Product, Distribution Channel, By End User - Global Industry Outlook, Key Companies (Elanco, Bayer, Dechra Pharmaceuticals, and others), Trends and Forecast 2023-2032

Published on : November-2023  Report Code : RC-620  Pages Count : 259  Report Format : PDF
Overview Table of Content Download Report's Excerpt Request Free Sample

Market Overview

The Global Animal Health Market is expected to reach a value of USD 67.4 billion in 2023, and it is further anticipated to reach a market value of USD 148.0 billion by 2032 at a CAGR of 9.1%.
Animal health means the well-being & functioning of both domestic & wild animals, covering their physical, mental, & behavioral aspects for a completely healthy & fulfilling life. It includes preventive healthcare, vaccinations, proper nutrition, & regular veterinary attention. Managing animal health is important for individual welfare & to minimize the spread of diseases affecting both animals & humans, which contributes significantly to sustainable agriculture, wildlife conservation, & the human-animal bond. 

Animal Health Market Growth Analysis

Key Takeaways

  • By Animal, the Production Animal segment takes the lead in 2023 & is anticipated to dominate throughout the forecasted period. 
  • In addition, the Companion Animal segment is expected to have significant growth over the forecasted period. 
  • By Distribution Channel, Hospital Pharmacy take the lead & drive the market in 2023 
  • North America has a 30.9% share of revenue in the global animal health market in 2023

Market Dynamic

Medicines play an important role for pet owners, veterinarians, farmers, & ranchers, ensuring animal welfare and reducing disease transmission between animals &* humans, thereby driving market revenue growth. Vaccination stands out as an affordable technique for preventing animal diseases. By stimulating the immune system without causing the disease, vaccines provide early exposure to pathogens, enabling the immune system to recall and respond effectively. Also, essential for diseases like rabies, vaccines contribute to preventing illnesses that still claim more than 60,000 human lives annually. Animals like sheep and goats, serving diverse purposes for income, food, and clothing, are susceptible to various infections, making monitoring and disease prevention vital.

However, challenges come from remote areas, as high costs of animal healthcare products restrict animal owners from proper care. Limited awareness leads to undiagnosed diseases & improper medication, impacting animal health. In addition, animal diseases have various implications on trade, food supply, livelihoods, & human health, posing potential obstacles to market revenue growth.

Research Scope and Analysis

By Animal Type

The global animal health market is categorized into production animal and companion animal segments. In 2023, the production animal segment claimed the largest revenue share, which includes poultry, swine, cattle, sheep & goats, and fish. Medicines play an essential role for pet owners, veterinarians, farmers, & ranchers, making sure of animal welfare, preventing disease transmission, & preserving the food supply. Further, the growing global population of livestock animals & the increase in demand for animal-derived food products like milk, meat, & fish are major factors driving the revenue growth in this segment.

Moreover, the companion animal segment is poised for high growth, driven by a growing demand for effective animal care & the strengthening bond between pets & humans. Companion animals, known for their positive impact on human health, like lowering blood pressure and providing psychological stability, are contributing to the growing popularity of animal-assisted therapy, boosting the growth of this segment in the coming future.

By Product

The global animal health market, segmented by product, includes vaccines, pharmaceuticals, feed additives, diagnostics, equipment & disposables, critical care consumables, & others. In 2023, the pharmaceuticals segment leads with the largest revenue share, a trend expected to persist throughout the forecast period. Pharmaceuticals play an important role in extending & enhancing the lives of animals, addressing conditions like diabetes, infections, obesity, pain, cancer, & age-related disorders, which includes a diverse range of solutions, from anti-inflammatory drugs to antibiotics, providing veterinarians and owners multiple administration options like pills, liquids, injections, powders, feed additives, and boluses.

Also, the veterinary diagnostics segment anticipates significant growth in the coming years, as factors contributing to this growth include increased animal health expenditure, growth in zoonotic diseases, & a rising number of veterinary practitioners with higher incomes in developed economies. Companies are investing heavily in expanding manufacturing facilities, positively influencing the animal health market. Further, the demand for point-of-care diagnostics is on the rise driving momentum in the Point of Care Diagnostics Market mainly among pet owners looking for tools like blood glucose monitors, pregnancy kits, & urinalysis strips. However, food animal diagnostics remain largely confined to labs due to strict requirements for disease testing in terms of sensitivity & efficacy.

By Distribution Channel

The hospital/clinic pharmacy segment secures the largest share of revenue in 2023, driven by the rising number of hospital pharmacies & a significant procedural volume, supporting strong segment growth. In addition, retail channels & e-commerce platforms play a significant role, collectively contributing to a substantial share of the total market, as the e-commerce segment is poised for high growth throughout the forecast period, fueled by advantages like growing convenience for patients resisting to purchase of medicines from traditional retail or hospital outlets.

Further, e-commerce platforms ensure a constant drug supply, allowing the convenient preordering of medications, and features anticipated to drive demand. Also, online pharmacies, facilitated by Supply Chain Management (SCM), simplify order procurement and tracking, reducing costs by eliminating intermediaries in the delivery channel, and ultimately improving customer preference. In parallel, retail pharmacies specializing in animal health products are expected to experience a moderate growth rate over the forecast period.

Animal Health Market distribution Analysis

By End User

The veterinary hospitals & clinics segment takes the lead in the animal health market in 2023, securing a significant share of the revenue, which is attributed to its diverse applications, including clinical pathology, toxicological tests, & therapy. The provision of a large spectrum of therapeutic & diagnostic solutions within veterinary hospitals & clinics stands out as a high-impact factor driving the growth of this segment.

Further, the point-of-care testing or in-house testing segment is expected to experience the fastest growth in the coming years. The projections come from factors like climate change & globalization, which are expected to increase the prevalence of zoonotic diseases, which in turn, will surge the demand for diagnostic procedures, driving the rapid advancement of the point-of-care testing or in-house testing segment in the coming future.

The Animal Health Market Report is segmented on the basis of the following:

By Animal Type

  •   Production Animal
  •   Companion Animal

 By Product

  • Vaccines
  • Pharmaceuticals
  • Feed Additives
  • Diagnostics
  • Equipment and Disposables
  • Critical Care Consumables
  • Others

By Distribution Channel

  • Retail Pharmacy
  • E-commerce
  • Hospital Pharmacy

By End User

  • Reference Laboratories
  • Point of care testing/ in-house testing
  • Veterinary Hospitals & Clinics 
  • Others

Regional Analysis

North America holds a dominant position in the animal health market, commanding a substantial 30.9% revenue share in 2023, which is attributed to the proactive measures undertaken by governments & animal welfare organizations, dedicated to improving overall animal health. The region benefits from technological developments in animal diagnostics, growth in awareness among pet owners, & a rise in zoonotic diseases. Collaborative initiatives by major companies to support research & development capabilities, ensuring strict quality standards, are anticipated to drive demand.

Animal Health Market Regional Analysis

In addition, the high occurrence of diseases in North America further solidifies its market dominance.
Also, the animal health market in the Asia Pacific is expected to have significant growth in the coming years, which is a direct result of consistent research & development investments by key industry players, focusing on introducing affordable branded & generic therapeutics. The region’s exponential growth is fueled by growing awareness of pet nutrition & supplies, along with a rise in earnings.

By Region

North America
  • The U.S.
  • Canada
Europe
  • Germany
  • The U.K.
  • France
  • Italy
  • Russia
  • Spain
  • Benelux
  • Nordic
  • Rest of Europe
Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • ANZ
  • ASEAN
  • Rest of Asia-Pacific
Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of Latin America
Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Israel
  • Egypt
  • Rest of MEA

Competitive Landscape

In the animal health market, to stay ahead of the competition, major companies have used various business tactics, like expanding into new regions, merging with or acquiring other companies, & engaging in collaborative research projects. These strategies focus on enhancing their competitive position by reaching new markets, strengthening capabilities, & encouraging innovation through partnerships with other organizations.

In September 2022, Merck Animal Health reported an updated label indication for Bravecto & BravectoPlus, enabling their topical use in cats to address Asian long-horned tick infestations. These products are the only ones in the U.S. authorized for treating & controlling this tick species. The Asian long-horned tick, originating from China, Japan, Eastern Russia, and Korea, is effectively targeted by Bravecto & BravectoPlus for feline applications.

Some of the prominent players in the global Animal Health Market are:
  • Elanco
  • Bayer
  • Dechra Pharmaceuticals
  • Neogen
  • Boehringer Ingelheim
  • Merck & Co, Inc.
  • Zoetis
  • Nutreco N.V.
  • Virbac
  • Vetquinol S.A.
  • Other Key Players

COVID-19 Pandemic & Recession: Impact on the Global Animal Health Market:

The COVID-19 pandemic and the following economic downturn have significantly influenced the global animal health market. The pandemic disturbed supply chains, impacting the availability & distribution of veterinary products. Lockdowns & restrictions led to fewer veterinary visits, impacting preventive care & vaccine administration for animals. In addition, economic uncertainties resulted in decreased disposable income, affecting pet ownership & spending on animal healthcare. However, the pandemic also highlighted the importance of the human-animal bond, leading to rising awareness about pet health. As economies recover, there is potential for the animal health market to rebound, driven by a renewed focus on pet well-being and an increased understanding of the link between animal health & human health.

Recent Developments

  • In January 2023, Nutreco & BiomEdit unveiled a major, extended partnership focusing on research & commercial efforts, which focuses on providing livestock producers with revolutionary feed additives created through microbiome technology. These innovative additives mainly target health & sustainability concerns in aquaculture, poultry, swine, & cattle, addressing important needs within the animal production industry.
  • In August 2022, the California Animal Welfare Funders Collaborative (CAWFC) allocated grants of about USD 300K to 19 organizations, focused on making a substantial impact on people & their pets statewide. The funds were directed toward providing necessities like proper food, medications, & diagnostics for pets, which highlights the growing emphasis on veterinary health, contributing significantly to the overall growth of the market
  • In January 2022, Zoetis unveiled that the US Food & Drug Administration (FDA) approved a new label indication for SimparicaTrio (sarolaner, moxidectin, &pyrantel chewable tablets), which signifies its efficiency in preventing Borrelia burgdorferi infections by targeting Ixodes scapularis vector ticks (black-legged or deer ticks). The approval extends to the usage of SimparicaTrio for dogs eight weeks & older age.

Report Details

                                  Report Characteristics
Market Size (2023) USD 67.4 Bn
Forecast Value (2032) USD 148.0 Bn
CAGR (2023-2032) 9.1%
Historical Data 2017 - 2022
Forecast Data 2023 - 2032
Base Year 2022
Estimate Year 2023
Report Coverage Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc.
Segments Covered By Animal Type (Production Animal and Companion Animal), By Product (Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, Equipment and Disposables, Critical Care Consumables, and Others), By Distribution Channel (Retail Pharmacy, E-commerce, and Hospital Pharmacy), By End User (Reference Laboratories, Point of care testing/ in-house testing, Veterinary Hospitals & Clinics, and Others)
Regional Coverage North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
Prominent Players Elanco, Bayer, Dechra Pharmaceuticals, Neogen, Boehringer Ingelheim, Merck & Co, Inc., Zoetis, Nutreco N.V., Virbac, Vetquinol S.A., and Other Key Players
Purchase Options We have three licenses to opt for: Single User License (Limited to 1 user), Multi-User License (Up to 5 Users), and Corporate Use License (Unlimited User) along with free report customization equivalent to 0 analyst working days, 3 analysts working days and 5 analysts working days respectively.

 

Frequently Asked Questions

  • How big is the Global Animal Health Market?

    The Global Animal Health Market size is estimated to have a value of USD 67.4 billion in 2023 and is expected to reach USD 148.0 billion by the end of 2032.

  • Which region accounted for the largest Global Animal Health Market?

    North America has the largest market share for the Global Animal Health Market with a share of about 30.9% in 2023.

  • Who are the key players in the Global Animal Health Market?

    Some of the major key players in the Global Animal Health Market are Elanco, Bayer, Dechra Pharmaceuticals, and many others.

  • What is the growth rate in the Global Animal Health Market?

    The market is growing at a CAGR of 9.1 percent over the forecasted period.

  • Contents

      1.Introduction
        1.1.Objectives of the Study
        1.2.Market Scope
        1.3.Market Definition and Scope
      2.Animal Health Market Market Overview
        2.1.Global Animal Health Market Market Overview by Type
        2.2.Global Animal Health Market Market Overview by Application
      3.Animal Health Market Market Dynamics, Opportunity, Regulations, and Trends Analysis
        3.1.Market Dynamics
          3.1.1.Animal Health Market Market Drivers
          3.1.2.Animal Health Market Market Opportunities
          3.1.3.Animal Health Market Market Restraints
          3.1.4.Animal Health Market Market Challenges
        3.2.Emerging Trend/Technology
        3.3.PESTLE Analysis
        3.4.PORTER'S Five Forces Analysis
        3.5.Technology Roadmap
        3.6.Opportunity Map Analysis
        3.7.Case Studies
        3.8.Opportunity Orbits
        3.9.Pricing Analysis
        3.10.Ecosystem Analysis
        3.11.Supply/Value Chain Analysis
        3.12.Covid-19 & Recession Impact Analysis
        3.13.Product/Brand Comparison
      4.Global Animal Health Market Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by By Animal Type, 2017-2032
        4.1.Global Animal Health Market Market Analysis by By Animal Type: Introduction
        4.2.Market Size and Forecast by Region
        4.3.  Production Animal
        4.4.  Companion Animal
      5.Global Animal Health Market Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by  By Product, 2017-2032
        5.1.Global Animal Health Market Market Analysis by  By Product: Introduction
        5.2.Market Size and Forecast by Region
        5.3.Vaccines
        5.4.Pharmaceuticals
        5.5.Feed Additives
        5.6.Diagnostics
        5.7.Equipment and Disposables
        5.8.Critical Care Consumables
        5.9.Others
      6.Global Animal Health Market Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by By Distribution Channel, 2017-2032
        6.1.Global Animal Health Market Market Analysis by By Distribution Channel: Introduction
        6.2.Market Size and Forecast by Region
        6.3.Retail Pharmacy
        6.4.E-commerce
        6.5.Hospital Pharmacy
      7.Global Animal Health Market Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by By End User, 2017-2032
        7.1.Global Animal Health Market Market Analysis by By End User: Introduction
        7.2.Market Size and Forecast by Region
        7.3.Reference Laboratories
        7.4.Point of care testing/ in-house testing
        7.5.Veterinary Hospitals & Clinics
        7.6.Others
      10.Global Animal Health Market Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2017-2032
        10.1.North America
          10.1.1.North America Animal Health Market Market: Regional Analysis, 2017-2032
            10.1.1.1.The US
            10.1.1.2.Canada
        10.2.1.Europe
          10.2.1.Europe Animal Health Market Market: Regional Trend Analysis
            10.2.1.1.Germany
            10.2.1.2.France
            10.2.1.3.UK
            10.2.1.4.Russia
            10.2.1.5.Italy
            10.2.1.6.Spain
            10.2.1.7.Nordic
            10.2.1.8.Benelux
            10.2.1.9.Rest of Europe
        10.3.Asia-Pacific
          10.3.1.Asia-Pacific Animal Health Market Market: Regional Analysis, 2017-2032
            10.3.1.1.China
            10.3.1.2.Japan
            10.3.1.3.South Korea
            10.3.1.4.India
            10.3.1.5.ANZ
            10.3.1.6.ASEAN
            10.3.1.7.Rest of Asia-Pacifc
        10.4.Latin America
          10.4.1.Latin America Animal Health Market Market: Regional Analysis, 2017-2032
            10.4.1.1.Brazil
            10.4.1.2.Mexico
            10.4.1.3.Argentina
            10.4.1.4.Colombia
            10.4.1.5.Rest of Latin America
        10.5.Middle East and Africa
          10.5.1.Middle East and Africa Animal Health Market Market: Regional Analysis, 2017-2032
            10.5.1.1.Saudi Arabia
            10.5.1.2.UAE
            10.5.1.3.South Africa
            10.5.1.4.Israel
            10.5.1.5.Egypt
            10.5.1.6.Turkey
            10.5.1.7.Rest of MEA
      11.Global Animal Health Market Market Company Evaluation Matrix, Competitive Landscape, Market Share Analysis, and Company Profiles
        11.1.Market Share Analysis
        11.2.Company Profiles
        11.3.Elanco
          11.3.1.Company Overview
          11.3.2.Financial Highlights
          11.3.3.Product Portfolio
          11.3.4.SWOT Analysis
          11.3.5.Key Strategies and Developments
        11.4.Bayer
          11.4.1.Company Overview
          11.4.2.Financial Highlights
          11.4.3.Product Portfolio
          11.4.4.SWOT Analysis
          11.4.5.Key Strategies and Developments
        11.5.Dechra Pharmaceuticals
          11.5.1.Company Overview
          11.5.2.Financial Highlights
          11.5.3.Product Portfolio
          11.5.4.SWOT Analysis
          11.5.5.Key Strategies and Developments
        11.6.Neogen
          11.6.1.Company Overview
          11.6.2.Financial Highlights
          11.6.3.Product Portfolio
          11.6.4.SWOT Analysis
          11.6.5.Key Strategies and Developments
        11.7.Boehringer Ingelheim
          11.7.1.Company Overview
          11.7.2.Financial Highlights
          11.7.3.Product Portfolio
          11.7.4.SWOT Analysis
          11.7.5.Key Strategies and Developments
        11.8.Merck & Co, Inc.
          11.8.1.Company Overview
          11.8.2.Financial Highlights
          11.8.3.Product Portfolio
          11.8.4.SWOT Analysis
          11.8.5.Key Strategies and Developments
        11.9.Zoetis
          11.9.1.Company Overview
          11.9.2.Financial Highlights
          11.9.3.Product Portfolio
          11.9.4.SWOT Analysis
          11.9.5.Key Strategies and Developments
        11.10.Nutreco N.V.
          11.10.1.Company Overview
          11.10.2.Financial Highlights
          11.10.3.Product Portfolio
          11.10.4.SWOT Analysis
          11.10.5.Key Strategies and Developments
        11.11.Virbac
          11.11.1.Company Overview
          11.11.2.Financial Highlights
          11.11.3.Product Portfolio
          11.11.4.SWOT Analysis
          11.11.5.Key Strategies and Developments
        11.12.Vetquinol S.A.
          11.12.1.Company Overview
          11.12.2.Financial Highlights
          11.12.3.Product Portfolio
          11.12.4.SWOT Analysis
          11.12.5.Key Strategies and Developments
        11.13.Other Key Players
          11.13.1.Company Overview
          11.13.2.Financial Highlights
          11.13.3.Product Portfolio
          11.13.4.SWOT Analysis
          11.13.5.Key Strategies and Developments
      12.Assumptions and Acronyms
      13.Research Methodology
      14.Contact
    If your country is missing in the list, we apologize that we still do not serve in your country.

    Your personal details are safe and secured with us.

    If your country is missing in the list, we apologize that we still do not serve in your country.

    Your personal details are safe and secured with us.

    Select License Type


    • RC-620

    • November-2023
      • ★★★★★
        ★★★★★
      • 47
    • $3190
    • $4590
    • $5690
    Download Free Brochure Customization Request Buy Country Level Reports Request Discount
    Chat on WhatsApp

    Get in Touch with Us

      USA Flag
    • UNITED STATES
      Phone: +1 732 369 9777
      India Flag
    • India
      Phone: +91 882 677 4855

    Recent Report

    • Pharma Quality Assurance Services Market
    • Pharmaceutical Drug Delivery Market
    • Cellulose Insulation Market
    • Remote Patient Monitoring Market
    • Molecular Diagnostics Market
    • Dental Consumables Market
    • Radioimmunoassay Market
    • Home Healthcare Services Market
    • Varicose Vein Treatment Market
    • Sleep Apnea Implants Market
    Secured Payment Options
      /images/payment.png
    Legal
    • Privacy Policy
    • Refund Policy
    • Frequently Asked Questions
    • Terms and Conditions
    Explore Company
    • About Us
    • Contact Us
    • Trending Reports
    • Latest Reports
    • All Industries
    • How to Order
    Contact Detail
    • 957 Route 33, Suite 12 #308
            Hamilton Square, NJ-08690 USA
    • +1 (123) 456 4562 (International)
    • +1 (609) 857 6083 (International)
    • +91 882 677 4855 (Asia)
    • sales@dimensionmarketresearch.com
    Copyright Market Research. ©2025 All rights reserved